Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma

计划入组 68 人 · 首次发布于 2014 年 10 月 21 日

A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors

计划入组 26 人 · 首次发布于 2007 年 2 月 21 日

Preventing FAS/ARND in Russian Children

计划入组 767 人 · 首次发布于 2013 年 10 月 11 日

FAS-115

FAS-3075

FAS-20013

Ligand Pharmaceuticals

United States

CEL-SCI

United States

Eledon Pharmaceuticals

United States

Asunercept Shows Promise in Reducing Mortality and Accelerating Recovery in Severe COVID-19

Oncolytic Virus and Toripalimab Combination Shows Promise in Acral Melanoma

Scinai to Acquire Pincell, Advancing Novel Antibody Treatment for Severe Skin Disorders